LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30243% above fair value
$13.77−0.40 (-2.82%)
Close on Nov 18, 2026Market cap $5.26BP/E 105.9Yield –
LifeStance Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
LifeStance Health's free cash flow for the twelve months ending Jun 30, 2026 was $173.91M, up 44.8% year over year. For fiscal 2025 it was $110.03M, up 28.4% from the year before. The highest annual figure on record is $110.03M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $110.03M | +28.4% |
| FY2024 | Dec 31, 2024 | $85.69M | – |
| FY2023 | Dec 31, 2023 | -$57.40M | – |
| FY2022 | Dec 31, 2022 | -$26.47M | – |
| FY2021 | Dec 31, 2021 | -$85.07M | -3211.6% |
| FY2019 | Dec 31, 2019 | $2.73M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $87.92M | +55.2% |
| Q1 FY2026 | Mar 31, 2026 | $22.34M | – |
| Q4 FY2025 | Dec 31, 2025 | $46.65M | -16.7% |
| Q3 FY2025 | Sep 30, 2025 | $17.00M | -3.8% |
| Q2 FY2025 | Jun 30, 2025 | $56.64M | +45.4% |
| Q1 FY2025 | Mar 31, 2025 | -$10.26M | – |
| Q4 FY2024 | Dec 31, 2024 | $56.02M | +941.0% |
| Q3 FY2024 | Sep 30, 2024 | $17.67M | – |
| Q2 FY2024 | Jun 30, 2024 | $38.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$26.94M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.38M | -78.9% |
| Q3 FY2023 | Sep 30, 2023 | -$35.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.62M | – |
| Q4 FY2022 | Dec 31, 2022 | $25.53M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.03M | – |
| Q1 FY2022 | Mar 31, 2022 | -$24.60M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.04M | – |
| Q3 FY2021 | Sep 30, 2021 | -$38.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$37.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$42.44M | – |
See a number that looks wrong?